A publicly trading stem cell company tied to leading industry names such as Inventive, James Andrews, Amen clinic doctors...
Leading technology for stem cell extraction that is highly effective, low cost and ease on patients.
By all appearances minimally manipulated per FDA, however INDs still required for clinical claims, aka marketing and insurance payments for treatment
Everything else about the insiders bungling funds, being arrogant, treating shareholders like rags is absolutely true IMO.. However, they just hastily had significant conversions of CD holders with CEO mysteriously getting 300 million shares now. You don't have to know squat about the company, but when volume is suddenly high under no PR campaign, fanfare, etc, somebody was accumulating and now after trading plenty of days with 50-200k in dollar volume, it barely can scrape up a few grand daily for the past 2 weeks...
INDs require funds. These funds would be separated from SVFC via a spin off entity or JV. Looks to me that all the inside position flooded the market with shares to dilute retail somewhat out of what happens next. It is BS, I agree. But the stage looks set for a significant run now..,'. Everybody got shares?
